{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:54:01Z","timestamp":1790790841526,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/cmi.2016.42","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T08:45:28Z","timestamp":1470645928000},"page":"158-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["CD5 expression promotes IL-10 production through activation of the MAPK\/Erk pathway and upregulation of TRPC1 channels in B lymphocytes"],"prefix":"10.1038","volume":"15","author":[{"given":"Soizic","family":"Garaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher E","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Debant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarra","family":"Melayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Berthou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Olivier","family":"Pers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Luque-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Chiocchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel","family":"Peppelenbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Isenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Youinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mignen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Renaudineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizgar A","family":"Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"BFcmi201642_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.immunol.20.100301.064833","volume":"20","author":"R Berland","year":"2002","unstructured":"Berland R, Wortis HH . Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20: 253\u2013300.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201642_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0065-2776(08)60512-X","volume":"55","author":"RR Hardy","year":"1994","unstructured":"Hardy RR, Hayakawa K, K . CD5B cells, a fetal B cell lineage. Adv Immunol 1994; 55: 297\u2013339.","journal-title":"Adv Immunol"},{"key":"BFcmi201642_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/nyas.12768","volume":"1362","author":"K Hayakawa","year":"2015","unstructured":"Hayakawa K, Formica AM, Colombo MJ, Ichikawa D, Shinton SA, Brill-Dashoff J et al. B cells generated by B-1 development can progress to chronic lymphocytic leukemia. Ann NY Acad Sci 2015; 1362: 250\u2013255.","journal-title":"Ann NY Acad Sci"},{"key":"BFcmi201642_CR4","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1182\/blood-2002-05-1525","volume":"100","author":"H Gary-Gouy","year":"2002","unstructured":"Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH . Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002; 100: 4537\u20134543.","journal-title":"Blood"},{"key":"BFcmi201642_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1006\/meth.1996.0393","volume":"11","author":"N Burdin","year":"1997","unstructured":"Burdin N, Rousset F, Banchereau J . B-cell-derived IL-10: production and function. Methods 1997; 11: 98\u2013111.","journal-title":"Methods"},{"key":"BFcmi201642_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683\u2013765.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201642_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1084\/jem.175.3.671","volume":"175","author":"T Defrance","year":"1992","unstructured":"Defrance T, Vanbervliet B, Bri\u00e8re F, Durand I, Rousset F, Banchereau J . Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175: 671\u2013682.","journal-title":"J Exp Med"},{"key":"BFcmi201642_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0925-5710(95)00395-9","volume":"62","author":"A Kitabayashi","year":"1995","unstructured":"Kitabayashi A, Hirokawa M, Miura AB . The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death. Int J Hematol 1995; 62: 99\u2013106.","journal-title":"Int J Hematol"},{"key":"BFcmi201642_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood.V97.1.256","volume":"97","author":"L Fayad","year":"2001","unstructured":"Fayad L, Keating MJ, Reuben JM, O\u2019Brien S, Lee BN, Lerner S et al. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 2001; 97: 256\u2013263.","journal-title":"Blood"},{"key":"BFcmi201642_CR10","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.4049\/jimmunol.179.7.4335","volume":"179","author":"H Gary-Gouy","year":"2007","unstructured":"Gary-Gouy H, Sainz-Perez A, Marteau JB, Marfaing-Koka A, Delic J, Merle-Beral H et al. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype. J Immunol 2007; 179: 4335\u20134344.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1749-6632.2009.04616.x","volume":"1173","author":"S Garaud","year":"2009","unstructured":"Garaud S, Le Dantec C, de Mendoza AR, Mageed RA, Youinou P, Renaudineau Y . IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann NY Acad Sci 2009; 1173: 280\u2013285.","journal-title":"Ann NY Acad Sci"},{"key":"BFcmi201642_CR12","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.4049\/jimmunol.1003050","volume":"186","author":"S Garaud","year":"2011","unstructured":"Garaud S, Morva A, Lemoine S, Hillion S, Bordron A, Pers JO et al. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation. J Immunol 2011; 186: 4835\u20134844.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR13","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1182\/blood-2012-12-474718","volume":"121","author":"B Apollonio","year":"2013","unstructured":"Apollonio B, Scielzo C, Bertilaccio MT, Ten Hacken E, Scarf\u00f2 L, Ranghetti P et al. Targeting B-cell anergy in chronic lymphocytic leukemia. Blood 2013; 121: 3879\u20133888.","journal-title":"Blood"},{"key":"BFcmi201642_CR14","doi-asserted-by":"publisher","first-page":"e64678","DOI":"10.1371\/journal.pone.0064678","volume":"8","author":"P Li","year":"2013","unstructured":"Li P, Grgurevic S, Liu Z, Harris D, Rozovski U, Calin GA et al. Signal transducer and activator of transcription-3 induces MicroRNA-155 expression in chronic lymphocytic leukemia. PLoS One 2013; 8: e64678.","journal-title":"PLoS One"},{"key":"BFcmi201642_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevImmunol.v24.i1.10","volume":"24","author":"MR Sarrias","year":"2004","unstructured":"Sarrias MR, Gr\u00f8nlund J, Padilla O, Madsen J, Holmskov U, Lozano F . The scavenger receptor cysteine-rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit Rev Immunol 2004; 24: 1\u201337.","journal-title":"Crit Rev Immunol"},{"key":"BFcmi201642_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1074\/jbc.275.1.548","volume":"275","author":"H Gary-Gouy","year":"2000","unstructured":"Gary-Gouy H, Bruhns P, Schmitt C, Dalloul A, Da\u00ebron M, Bismuth G . The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem 2000; 275: 548\u2013556.","journal-title":"J Biol Chem"},{"key":"BFcmi201642_CR17","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.4049\/jimmunol.159.8.3739","volume":"159","author":"H Gary-Gouy","year":"1997","unstructured":"Gary-Gouy H, Lang V, Sarun S, Boumsell L, Bismuth G . In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+ thymocytes. J Immunol 1997; 159: 3739\u20133747.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR18","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/leu.2011.152","volume":"25","author":"E Tibaldi","year":"2011","unstructured":"Tibaldi E, Brunati AM, Zonta F, Frezzato F, Gattazzo C, Zambello R et al. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 2011; 25: 1768\u20131781.","journal-title":"Leukemia"},{"key":"BFcmi201642_CR19","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1128\/MCB.19.4.2903","volume":"19","author":"JJ Perez-Villar","year":"1999","unstructured":"Perez-Villar JJ, Whitney GS, Bowen MA, Hewgill DH, Aruffo AA, Kanner SB . CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol 1999; 19: 2903\u20132912.","journal-title":"Mol Cell Biol"},{"key":"BFcmi201642_CR20","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2167::AID-IMMU2167>3.0.CO;2-L","volume":"28","author":"A Bauch","year":"1998","unstructured":"Bauch A, Campbell KS, Reth M . Interaction of the CD5 cytoplasmic domain with the Ca2+\/calmodulin-dependent kinase IIdelta. Eur J Immunol 1998; 28: 2167\u20132177.","journal-title":"Eur J Immunol"},{"key":"BFcmi201642_CR21","doi-asserted-by":"publisher","first-page":"19183","DOI":"10.1074\/jbc.273.30.19183","volume":"273","author":"C Raman","year":"1998","unstructured":"Raman C, Kuo A, Deshane J, Litchfield DW, Kimberly RP . Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5. J Biol Chem 1998; 273: 19183\u201319189.","journal-title":"J Biol Chem"},{"key":"BFcmi201642_CR22","doi-asserted-by":"publisher","first-page":"30707","DOI":"10.1074\/jbc.M202460200","volume":"277","author":"SC Wong","year":"2002","unstructured":"Wong SC, Chew WK, Tan JE, Melendez AJ, Francis F, Lam KP . Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J Biol Chem 2002; 277: 30707\u201330715.","journal-title":"J Biol Chem"},{"key":"BFcmi201642_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4049\/jimmunol.168.1.232","volume":"168","author":"H Gary-Gouy","year":"2002","unstructured":"Gary-Gouy H, Harriague J, Dalloul A, Donnadieu E, Bismuth G . CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. J Immunol 2002; 168: 232\u2013239.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1084\/jem.191.5.883","volume":"191","author":"KL Hippen","year":"2000","unstructured":"Hippen KL, Tze LE, Behrens TW . CD5 maintains tolerance in anergic B cells. J Exp Med 2000; 191: 883\u2013890.","journal-title":"J Exp Med"},{"key":"BFcmi201642_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/blood-2008-04-150987","volume":"113","author":"K Parikh","year":"2009","unstructured":"Parikh K, Poppema S, Peppelenbosch MP, Visser L . Extracellular ligation-dependent CD45RB enzymatic activity negatively regulates lipid raft signal transduction. Blood 2009; 113: 594\u2013603.","journal-title":"Blood"},{"key":"BFcmi201642_CR26","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES . The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117: 5019\u20135032.","journal-title":"Blood"},{"key":"BFcmi201642_CR27","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood.V87.12.5113.bloodjournal87125113","volume":"87","author":"HJ Gross","year":"1996","unstructured":"Gross HJ, Merling A, Moldenhauer G, Schwartz-Albiez R . Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. Blood 1996; 87: 5113\u20135126.","journal-title":"Blood"},{"key":"BFcmi201642_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-4598-10-42","volume":"10","author":"S Loisel","year":"2011","unstructured":"Loisel S, Andr\u00e9 PA, Golay J, Buchegger F, Kadouche J, C\u00e9rutti M et al. Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia. Mol Cancer 2011; 10: 42.","journal-title":"Mol Cancer"},{"key":"BFcmi201642_CR29","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/art.27509","volume":"62","author":"V Devauchelle-Pensec","year":"2010","unstructured":"Devauchelle-Pensec V, Cagnard N, Pers JO, Youinou P, Saraux A, Chiocchia G . Gene expression profile in the salivary glands of primary Sjogren\u2019s syndrome patients before and after treatment with rituximab. Arthritis Rheum 2010; 62: 2262\u20132271.","journal-title":"Arthritis Rheum"},{"key":"BFcmi201642_CR30","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.4049\/jimmunol.166.6.3855","volume":"166","author":"JD Richards","year":"2001","unstructured":"Richards JD, Dav\u00e9 SH, Chou CH, Mamchak AA, DeFranco AL . Inhibition of the MEK\/ERK signaling pathway blocks a subset of B cell responses to antigen. J Immunol 2001; 166: 3855\u20133864.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR31","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.4049\/jimmunol.174.6.3749","volume":"174","author":"S N\u00e9dellec","year":"2005","unstructured":"N\u00e9dellec S, Renaudineau Y, Bordron A, Berthou C, Porakishvili N, Lydyard PM et al. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients. J Immunol 2005; 174: 3749\u20133756.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbrc.2013.01.086","volume":"432","author":"NS Roa","year":"2013","unstructured":"Roa NS, Ordo\u00f1ez-Rueda D, Ch\u00e1vez-Rios JR, Raman C, Garc\u00eda-Zepeda EA, Lozano F et al. The carboxy-terminal region of CD5 is required for c-CBL mediated TCR signaling downmodulation in thymocytes. Biochem Biophys Res Commun 2013; 432: 52\u201359.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcmi201642_CR33","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1084\/jem.186.11.1897","volume":"186","author":"AM Buhl","year":"1997","unstructured":"Buhl AM, Pleiman CM, Rickert RC, Cambier JC . Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization. J Exp Med 1997; 186: 1897\u20131910.","journal-title":"J Exp Med"},{"key":"BFcmi201642_CR34","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0006-2952(02)01263-7","volume":"64","author":"J Chen","year":"2002","unstructured":"Chen J, Fang Y . A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. Biochem Pharmacol 2002; 64: 1071\u20131077.","journal-title":"Biochem Pharmacol"},{"key":"BFcmi201642_CR35","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1172\/JCI119869","volume":"100","author":"DA Frank","year":"1997","unstructured":"Frank DA, Mahajan S, Ritz J . B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J Clin Invest 1997; 100: 3140\u20133148.","journal-title":"J Clin Invest"},{"key":"BFcmi201642_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/leu.2014.188","volume":"29","author":"AF Muggen","year":"2015","unstructured":"Muggen AF, Pillai SY, Kil LP, van Zelm MC, van Dongen JJ, Hendriks RW et al. Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia. Leukemia 2015; 29: 321\u2013328.","journal-title":"Leukemia"},{"key":"BFcmi201642_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1074-7613(00)80285-X","volume":"6","author":"JI Healy","year":"1997","unstructured":"Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997; 6: 419\u2013428.","journal-title":"Immunity"},{"key":"BFcmi201642_CR38","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.169.4.1735","volume":"169","author":"MJ Chumley","year":"2002","unstructured":"Chumley MJ, Dal Porto JM, Cambier JC . The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J Immunol 2002; 169: 1735\u20131743.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR39","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","volume":"105","author":"GP Sims","year":"2005","unstructured":"Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE . Identification and characterization of circulating human transitional B cells. Blood 2005; 105: 4390\u20134398.","journal-title":"Blood"},{"key":"BFcmi201642_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/ni.2016","volume":"12","author":"A Limnander","year":"2011","unstructured":"Limnander A, Depeille P, Freedman TS, Liou J, Leitges M, Kurosaki T et al. STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol 2011; 12: 425\u2013433.","journal-title":"Nat Immunol"},{"key":"BFcmi201642_CR41","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1128\/MCB.01699-13","volume":"34","author":"A Limnander","year":"2014","unstructured":"Limnander A, Zikherman J, Lau T, Leitges M, Weiss A, Roose JP . Protein kinase Cdelta promotes transitional B cell-negative selection and limits proximal B cell receptor signaling to enforce tolerance. Mol Cell Biol 2014; 34: 1474\u20131485.","journal-title":"Mol Cell Biol"},{"key":"BFcmi201642_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","volume":"112","author":"M Muzio","year":"2008","unstructured":"Muzio M, Apollonio B, Scielzo C, Frenquelli M, Vandoni I, Boussiotis V et al. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 2008; 112: 188\u2013195.","journal-title":"Blood"},{"key":"BFcmi201642_CR43","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/BF02982115","volume":"75","author":"K Kawauchi","year":"2002","unstructured":"Kawauchi K, Ogasawara T, Yasuyama M . Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia. Int J Hematol 2002; 75: 508\u2013513.","journal-title":"Int J Hematol"},{"key":"BFcmi201642_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/leu.2013.358","volume":"28","author":"S Cheng","year":"2014","unstructured":"Cheng S, Ma J, Guo A, Lu P, Leonard JP, Coleman M et al. BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity. Leukemia 2014; 28: 649\u2013657.","journal-title":"Leukemia"},{"key":"BFcmi201642_CR45","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.4049\/jimmunol.181.3.2010","volume":"181","author":"S Garaud","year":"2008","unstructured":"Garaud S, Le Dantec C, Berthou C, Lydyard PM, Youinou P, Renaudineau Y . Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J Immunol 2008; 181: 2010\u20132018.","journal-title":"J Immunol"},{"key":"BFcmi201642_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.20011758","volume":"195","author":"Y Mori","year":"2002","unstructured":"Mori Y, Wakamori M, Miyakawa T, Hermosura M, Hara Y, Nishida M et al. Transient receptor potential 1 regulates capacitative Ca(2+) entry and Ca(2+) release from endoplasmic reticulum in B lymphocytes. J Exp Med 2002; 195: 673\u2013681.","journal-title":"J Exp Med"},{"key":"BFcmi201642_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lfs.2006.08.021","volume":"80","author":"AS Roedding","year":"2006","unstructured":"Roedding AS, Li PP, Warsh JJ . Characterization of the transient receptor potential channels mediating lysophosphatidic acid-stimulated calcium mobilization in B lymphoblasts. Life Sci 2006; 80: 89\u201397.","journal-title":"Life Sci"},{"key":"BFcmi201642_CR48","doi-asserted-by":"publisher","first-page":"L539","DOI":"10.1152\/ajplung.00389.2011","volume":"303","author":"E Yildirim","year":"2012","unstructured":"Yildirim E, Carey MA, Card JW, Dietrich A, Flake GP, Zhang Y et al. Severely blunted allergen-induced pulmonary Th2 cell response and lung hyperresponsiveness in type 1 transient receptor potential channel-deficient mice. Am J Physiol Lung Cell Mol Physiol 2012; 303: L539\u2013L549.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFcmi201642_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrrheum.2013.7","volume":"9","author":"JJ O\u2019Shea","year":"2013","unstructured":"O\u2019Shea JJ, Laurence A, McInnes IB . Back to the future: oral targeted therapy for RA and other autoimmune diseases. Nat Rev Rheumatol 2013; 9: 173\u2013182.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201642.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201642","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cmi.2016.42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201642.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:25:12Z","timestamp":1672745112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFcmi201642"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2016.42","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]},"assertion":[{"value":"21 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}